Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,727,600 | 1,748,100 | 1,430,100 | 404,600 | 4,060,500 |
| Depreciation Amortization | 1,117,000 | 982,300 | 805,700 | 146,900 | 457,200 |
| Income taxes - deferred | -426,800 | -750,100 | -622,800 | -15,000 | 149,000 |
| Accounts receivable | 324,800 | 157,800 | 211,500 | 37,200 | 2,800 |
| Other Working Capital | -145,500 | -221,700 | -105,200 | -331,200 | -187,200 |
| Other Operating Activity | 1,042,800 | 885,200 | 277,000 | 526,500 | -252,500 |
| Operating Cash Flow | $3,639,900 | $2,801,600 | $1,996,300 | $769,000 | $4,229,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -258,100 | -206,500 | -164,500 | -92,600 | -424,800 |
| Net Acquisitions | 28,100 | 28,100 | 28,100 | 28,100 | -1,006,500 |
| Purchase Of Investment | -3,808,700 | -2,372,600 | -1,626,900 | -913,300 | -6,397,700 |
| Sale Of Investment | 3,498,900 | 2,119,300 | 1,543,900 | 910,400 | 7,374,300 |
| Purchase Sale Intangibles | -18,800 | -19,900 | 0 | N/A | -127,000 |
| Other Investing Activity | -23,900 | -19,300 | 2,000 | 2,700 | -153,900 |
| Investing Cash Flow | $-563,700 | $-451,000 | $-217,400 | $-64,700 | $-608,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 2,967,400 |
| Debt Repayment | -170,000 | -170,000 | -170,000 | -169,300 | -1,500,000 |
| Common Stock Issued | N/A | -8,300 | -14,200 | -27,100 | -4,600 |
| Common Stock Repurchased | -1,800,000 | -1,800,000 | -1,050,000 | -600,000 | -6,679,100 |
| Other Financing Activity | -116,200 | -117,700 | -115,300 | 11,400 | -56,400 |
| Financing Cash Flow | $-2,086,200 | $-2,096,000 | $-1,349,500 | $-785,000 | $-5,272,700 |
| Exchange Rate Effect | -59,800 | -44,000 | -18,600 | -33,000 | 69,000 |
| Beginning Cash Position | 1,331,200 | 1,331,200 | 1,331,200 | 1,331,200 | 2,913,700 |
| End Cash Position | 2,261,400 | 1,541,800 | 1,742,000 | 1,217,500 | 1,331,200 |
| Net Cash Flow | $930,200 | $210,600 | $410,800 | $-113,700 | $-1,582,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,639,900 | 2,801,600 | 1,996,300 | 769,000 | 4,229,800 |
| Capital Expenditure | -258,100 | -206,500 | -164,500 | -92,600 | -424,800 |
| Free Cash Flow | 3,381,800 | 2,595,100 | 1,831,800 | 676,400 | 3,805,000 |